Prescription digital therapeutics platform supporting web, mobile, and VR technologies for mental health treatment

Prescription Digital Therapeutics
Limbix is actively researching and productizing therapies for a new therapeutic class: Prescription Digital Therapeutics. PDTs require strict compliance with FDA quality management standards, are put through rigorous research trials, and in certain cases can be paired with existing pharmacological treatments. Upon FDA approval, PDTs support medical claims and can be prescribed similarly to traditional drugs.

Do you have protocols you want to commercialize?

Limbix is interested in collaborations to validate and commercialize existing research protocols that leverage technology for mental health treatment. Contact research@limbix.com